Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: Implications for adoptive immunotherapy with T cells

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 587-594

  Lewalle, P ^a   Hensel, N ^a   Guimaraes, A ^b   Couriel, D ^a   Jiang, Y Z ^a   Mavroudis, D ^a   Barrett, A J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Adoptive immunotherapy; Antileukaemia cytotoxicity; Chronic myeloid leukaemia; Cytotoxic T cells; Helper T cells

Indexed keywords

ALPHA INTERFERON; BUSULFAN; HYDROXYUREA;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MALE; PRIORITY JOURNAL;

ADULT; CELL DIVISION; DISEASE PROGRESSION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, LYMPHOKINE-ACTIVATED; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR CELLS, CULTURED;

EID: 0029919074     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ashman, K.L., O'Keefe, E.D. & Michaels, S.R. (1986) Autologous responses to human leukemia cells. Cancer Immunology and Immunotherapy, 22, 95-99.
2. Barrett, A.J., Guimarães, A., Cullis, J.O. & Goldman, J.M. (1993) Immunological characterisation of the tumor-specific junction on Philadelphia chromosome positive chronic myeloid leukemia. Stem Cells. 11, (Suppl. 3), 104-108.
3. Barrett, A.J. & Jiang, Y.Z. (1992) Immune responses to chronic myeloid leukemia. Bone Marrow Transplantation, 9, 305-311.
4. Butturini, A. & Gale, R.P. (1987) The role of T cells in preventing relapse in chronic myelogenous leukemia. Bone Marrow Transplantation, 2, 351-354.
5. Faber, L.M., van Luxemberg-Heijs, S.A.P., Willemze, R. & Falkenberg, J.H. (1992) Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical hone marrow donor of a patient with leukemia. Journal of Experimental Medicine, 176, 1283-1289.
6. Hoffman, T., Theobald, M., Bunjes, D., Weiss, M., Heimpel, H. & Heit, W. (1993) Frequency of bone marrow T cells responding to HLA identical non-leukemia and leukemic stimulators. Bone Marrow Transplantation, 12, 1-8.
7. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H-J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Fruitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukaemia reactions after hone marrow transplantation. Blood, 75, 555-562.
8. Khene, A.G., Advani, S.H. & Gengal, S.G. (1981) In vitro generation of lymphocytotoxicity to autochthonous leukaemia cells in chronic myelogenous leukaemia. British Journal of Cancer, 43, 13.
9. Kolb, H.J., Mitmuller, J., Clemm, Ch., Holler, E., Ledderose, G., Brehm, G., Heim, M. & Wilmans, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
10. Lee, S.K. & Oliver, R.T.D. (1978) Autologous leukaemia-specific T cell mediated lymphocytotoxicity in patients with acute myelogenous leukemia. Journal of Experimental Medicine, 147, 912-922.
11. Leventhal, B.G., Mirro, J. & Konior Yarbo, G.S. (1978) Immune reactivity to tumor antigens in leukemia and lymphoma. Seminars in Hematology, 15, 157-163.
12. Ortaldo, J.R. & Bonnard, G.D. (1977) Presence of natural killer cell activity in cytotoxic lymphocytes from MLC-CML reactions. Federation Proceedings, 35, 1325.
13. Ostrand, S. & Rosenberg, S. (1994) Tumor immunotherapy: the tumor cell as antigen presenting cell. Current Opinion in Immunology, 6, 722-727.
14. Pawelec, G., Ehninger, G. & Schmidt, H. (1990) Susceptibility of aulologous target cells to lysis by lymphokine activated effectors from interferon treated chronic myelogenous leukemia patients. Cancer Immunology and Immunotherapy, 32, 167-172.
15. Pawelec, G., Kalbacher, H. & Bruserud, O. (1992) Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocations. Oncology Research, 4, 315-320.
16. Pawelec, G., Schmidt, H. & Busch, F. (1989) Antitumor activity in vitro in chronic myelogenous leukemia revealed after treating peripheral cells with cytosine arabinoside. Cancer Immunology and Immunotherapy, 29, 242-246.
17. Schwarer, A.P., Jiang, Y.Z., Brookes, P.A., Barrett, A.J., Batchelor, J.R., Goldman, J.M. & Lechler, R.I. (1995) Frequency of antirecipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Lancet, 341, 203-205.
18. Sharrock, C.E.M., Kaminski, E. & Man, S. (1990) Limiting dilution analysis of human T-cells: a useful clinical tool. Immunology Today, 11, 281-286.
19. Somasunduaram, R., Advani, S.H. & Gengal, G. (1988a) Proliferation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells. Cancer Immunology and Immunotherapy, 27, 183-189.
20. Somasundaram, R., Rao, S.G.A., Advani, S.H. & Gengal, S.G. (1988b) In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission. Cancer Immunology and Immunotherapy, 27, 177-182.
21. Teichmann, J.V., Ludwig, W.-D. & Thiel, E. (1992) Cytotoxicity of IL-2 induced lymphokine activated killer (LAK) cells against human leukemia and augmentation of killing by interferon and tumor necrosis factor. Leukemia Research, 16, 287-298.
22. Theobald, M., Nierle, T., Bunjes, D., Arnold, R. & Heimpel, H. (1992) Host-specific interleukin-2-secreting donor T cell precursors as predictors of acute graft-versus-host disease in hone marrow transplantation between HLA-identical siblings. New England Journal of Medicine, 327, 1614-1617.
23. + T cells in cancer immunotherapy. Current Opinion in Immunology, 6, 741-745.
24. Tosato, G. (1994) Generation of Epstein-Barr virus (EBV) immortalized B cell lines. Current Protocols in Immunology (ed. by J. E., Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach and W. Strober), Vol. 1, p. 7.22.1. Library of Congress, Washington.
25. van Rhee, F., Feng, L., Cullis, J.O., Spencer, A., Cross, N.P.C., Chase, A., Garicichoa, B., Bungay, J., Barrett, A.J. & Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation: the case for giving donor leukocyte transfusions before the onset of hematological relapse. Blood, 83, 3377-3383.
26. Wang, X.M., Terasaki, P.I., Rankin, G.W., Chia, D., Zhong, H.P. & Hardy, S. (1995) A new microcellular cytotoxicity test based on calcein AM release. Human Immunology, 37, 264-270.
27. Zarling, J.M., Raich, P.C., McKeough, M. & Bach, F.H. (1976) Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature, 262, 691.